Fire at Sun Pharma API factory kills two

By Melissa Fassbender

- Last updated on GMT

On December 28, a fire broke out at Sun Pharma’s Ahmednagar factory. (Image: iStock/gdpozzi)
On December 28, a fire broke out at Sun Pharma’s Ahmednagar factory. (Image: iStock/gdpozzi)

Related tags Pharmacology Pharmacy

Late last week, a fire at Sun Pharmaceutical Industries Limited’s Ahmednagar factory, which manufactures APIs, sent four employees to the hospital.

In a response letter​ to the National Stock Exchange of India Ltd, compliance officer for Sun Pharmaceutical Industries Limited, Ashok I Bhuta, confirmed that a fire broke out at the company’s Ahmednagar factory on December 28, 2016 during excavation work.

The fire injured four employees, all of whom were immediately transported to a nearby hospital. According to the letter, two of the injured workmen “succumbed to burn injuries​.”

The other two are said to be responding well to treatment.

We are currently investigating the matter with the help of local law enforcement​,” the response letter added – the summation of which was reiterated in the company's emailed statement on the incident.

According to the company, there has been no loss of production at the factory as a result of the incident.

Related news

Show more

Related products

show more

Increasing the Bioavailability of Oncology Drugs

Increasing the Bioavailability of Oncology Drugs

Content provided by Lonza Small Molecules | 13-Nov-2023 | White Paper

Oral tyrosine kinase inhibitors (TKIs) are a class of cancer drugs that can be highly susceptible to issues with solubility in the gastrointestinal tract

Efficient Freezing & Storage of Biopharmaceuticals

Efficient Freezing & Storage of Biopharmaceuticals

Content provided by Single Use Support | 06-Nov-2023 | White Paper

Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...

Manufacturing Drugs with Highly Potent APIs

Manufacturing Drugs with Highly Potent APIs

Content provided by Altasciences | 28-Sep-2023 | White Paper

In this issue of The Altascientist, we examine the critical considerations for the safe and compliant manufacture of drugs with highly potent APIs (HPAPIs),...

Follow us

Products

View more

Webinars